Esperite N.V. (Euronext: ESP) announces that it has postponed the Extraordinary General Meeting of Shareholders (EGM) originally scheduled on 26 March 2020 at 14:00 hours CET to 30th April 2020 at 14:00 hours CET, in order to avoid unnecessary travel risks.

Esperite invites its shareholders for the EGM at the

Hotel NH – Barbizon Palace, Prins Hendrikkade 59-72,

1012 AD Amsterdam

***

PDF Downloads – EGM 30 April 2020

           Press Release : EGM-30-April-2020-Press-Release-SMF.pdf

          Agenda  :             EGM-30-April-2020-Agenda.pdf

          Notice  :               EGM-30-April-2020-Notice.pdf

Explanatory Notes :  EGM-30-April-2020-Explanatory-Notes.pdf

Power of Attorney :   EGM-30-April-2020-Power-of-Attorney.pdf   

read more

 24 February 2020

***

Esperite announces its decision to oppose the Dutch Authority for the Financial Markets (AFM) who levied a fine on the company

read more

  17 February 2020

Esperite update the market

Esperite NV (Esperite, The Company) updates its shareholders on the current configuration and business of the company.

The company has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.

***

read more

ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020

Amsterdam, The Netherlands – 13 February 2020

***

PDF Downloads – EGM 26 March 2020

           Press Release :  EGM-26-March-2020-Press-Release-1.pdf

          Agenda  :              EGM-26-March-2020-Agenda-1.pdf

          Notice  :                EGM-26-March-2020-Notice-1.pdf

Explanatory Notes :   EGM-26-March-2020-Explanatory-Notes-1.pdf

Power of Attorney :    EGM-26-March-2020-Power-of-Attorney-1.pdf

read more

ESPERITE N.V: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.

Amsterdam, The Netherlands – 10 February 2020

***

read more

ESPERITE (ESP) is not bankrupt.  

Amsterdam, The Netherlands – 30 October 2019

***

 This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

read more

ESPERITE (ESP) disputes the Court verdict and appeals the order.

Amsterdam, The Netherlands – 14 October 2019

To learn more about the ESPERITE Group, info@esperitegroup.com or visit the website at www.esperite.com,

***

 This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

read more

Esperite N.V. (ESP): Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.

Amsterdam, The Netherlands – 30 September 2019 read more

CryoSave has maintained without compromise the highquality processing and storage services and has handed over its whole business.

Switzerland – 19 September 2019
read more

ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS

Amsterdam, The Netherlands – 27 August 2019
read more